题名

胎動不安合併子懸之中西醫結合治療病例報告

并列篇名

Treatment of Postpartum Preterm Labor with Zi-xuan by Integrative Medicine: A Case Report

DOI

10.6516/TJTCM.202206_25(2).0005

作者

許雅婷(Ya-Ting Hsu);陳怡伶(Yi-Lin Chen);廖苑伶(Yuan-Ling Liao);林亞萱(Ya-Hsuan Lin);吳炫璋(Hsien-Chang Wu)

关键词

早產 ; 胎動不安 ; 子懸 ; 安胎 ; 中西醫結合治療 ; preterm labor ; Zi-xuan ; tocolysis ; Integrative Medicine

期刊名称

中醫藥研究論叢

卷期/出版年月

25卷2期(2022 / 06 / 30)

页次

69 - 81

内容语文

繁體中文

中文摘要

35歲孕婦,G1P0A0,2020/01/04(妊娠週數為23+2週)陰道有水狀分泌物流出,無宮縮感,子宮頸長度為2.16公分,因子宮頸閉鎖不全且子宮頸長度持續性縮短,安排住院安胎,施打安胎針劑(Ritodrine)。住院期間孕婦持續有胸腹脹滿、心煩少寐等的症狀,服用西藥後仍症狀反覆,2020/03/06(妊娠週數為32+2週)會診中醫治療,辨證為肝胃不和、心肝血虛有熱之胎動不安合併子懸,配合疏肝理氣,滋陰清熱,養血安胎中藥治療後,不僅宮縮頻率減少、安胎針劑劑量減少且腹脹、眠差等主要症狀與簡式健康量表分數均改善,孕婦於妊娠週數35+5週自然產下一健康男嬰。由此病例我們討論中西醫合療安胎的療效與注意事項,以供臨床醫師參考。

英文摘要

A 35-year-old pregnant woman (G1P0A0) had watery vaginal discharge on 2020/01/04 at a gestational age (GA) of 23+2 weeks, with a cervical length of 2.16 cm and no uterine contraction. Due to cervical incompetence with progressive shortening of cervical length, she was admitted to our hospital to receive tocolytic treatment (ritodrine). During hospitalization, the patient suffered from abdominal distension and poor sleep quality, which kept recurring even after taking Western medicine. She received traditional Chinese medicine (TCM) treatment for symptom relief on 2020/03/06 at a GA of 32+2 weeks. The TCM differential diagnosis revealed Zi-xuan with liver-stomach disharmony and heart and liver blood deficiency with heat. The TCM treatment dispersed and rectified the stagnated liver Qi, nourished yin, cleared heat, and tonified the blood to prevent miscarriage. Following the TCM treatment, the uterine contraction frequency and tocolytic drug dosage were reduced. The main symptoms (i.e., abdominal distension and poor sleep) and the simple health scale scores improved. Finally, she gave birth to a healthy baby boy at a GA of 35+5 weeks. From this case, the efficacy and precautions in combining the TCM and Western medicine treatments for tocolysis can be discussed.

主题分类 醫藥衛生 > 中醫藥學
醫藥衛生 > 藥理醫學
参考文献
  1. 王隆碩,陳豪君,李俊廷(2014)。臨床常用安胎中藥機轉與安全性探討。中醫藥研究論叢,17(1),57-68。
    連結:
  2. 趙穎,簡煥玲,廖慧慧(2018)。張玉珍教授安胎學術思想及經驗介紹。中醫婦科醫學雜誌,22,7-14。
    連結:
  3. (明)張介賓(2017).景岳全書.北京:中國醫藥科技出版社.
  4. (清)吳謙(2016).醫宗金鑒-婦科心法要訣.臺北:新文豐出版公司.
  5. (清)傅山,肖承悰(編)(2015).傅青主女科.北京:人民衛生出版社.
  6. Charles J Lockwood M. (2020). Preterm labor: Clinical findings, diagnostic evaluation, and initial treatment. UpToDate. Retrieved data from https://www-uptodate-com.tpsw.tzuchi.com.tw/contents/preterm-labor-clinical-findings-diagnostic-evaluation-and-initial-treatment.
  7. Kim, MK,Lee, SM,Oh, JW,Kim, SY,Jeong, HG,Kim, SM(2018).Efficacy and side effect of ritodrine and magnesium sulfate in threatened preterm labor.Obstet Gynecol Sci,61(1),63-70.
  8. Li, L,Dou, LX,Neilson, JP,Leung, PC,Wang, CC(2012).Adverse outcomes of Chinese medicines used for threatened miscarriage: a systematic review and meta-analysis.Hum Reprod Update,18(5),504-524.
  9. Li, L,Leung, PC,Chung, TKH,Wang, CC(2014).Systematic Review of Chinese Medicine for Miscarriage during Early Pregnancy.Evidence-Based Complementary and Alternative Medicine,2014,753856.
  10. Pharmacovigilance Risk Assessment Committee. Assessment report for Short Acting Beta Agonists (SABAs) containing medicinal products authorised in obstetric indications. European Medicine Agency. 2013. https://www.ema.europa.eu/en/documents/referral/short-acting-beta-agonists-article-31-referral-prac-assessment-report_en.pdf
  11. The American College of Obstetricians and Gynecologists(2016).Practice Bulletin No. 171: Management of Preterm Labor.OBSTETRICS & GYNECOLOGY,128(4),e155-e164.
  12. Wen, SH,Chang, WC,Shen, HS,Wu, HC(2020).Prescription patterns and factors influencing the use of Chinese herbal medicine among pregnant women in Taiwan: a population-based retrospective study.BMC Complement Med Ther,20(1),240.
  13. Yaju, Y,Nakayama, T(2006).Effectiveness and safety of ritodrine hydrochloride for the treatment of preterm labour: a systematic review.Pharmacoepidemiol Drug Saf,15(11),813-822.
  14. Younger, JD,Reitman, E,Gallos, G(2017).Tocolysis: Present and future treatment options.Semin Perinatol,41(8),493-504.
  15. 杜惠蘭(編)(2016).中西醫結合婦產科學.北京:中國中醫藥出版社.
  16. 周雨鋼,林綺詩,劉夷生(2017)。早產現象的評估與處置。家庭醫學與基層醫療,32(7),194-200。
  17. 孟俠,楊智玲,葉禮翠,向睿。固元穩胎湯結合鹽酸利托君對先兆流產患者子宮動力學的影響及安全性研究。中華中醫藥學刊
  18. 梁啟軍,曾茹,周琳(2018)。妊娠禁忌與安胎中藥。中醫雜誌,59(23),2068-2070。
  19. 陳立德,陳榮洲,陳建霖,張白欣,邱燦宏,陳雅吟,謝佳蓉(2006).中醫婦科學.台中:弘祥出版社.
  20. 劉俊華(2015)。壽胎丸加味聯合利托君和護理干預治療胎膜早破型先兆早產的臨床研究。時珍國醫國藥,2015(07),1681-1683。
  21. 羅頌平,談勇(2015).中醫婦科學.北京:人民衛生出版社.